Ardsley Advisory Partners LP Buys Shares of 110,000 CVS Health Corporation $CVS

Ardsley Advisory Partners LP bought a new position in shares of CVS Health Corporation (NYSE:CVS) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 110,000 shares of the pharmacy operator’s stock, valued at approximately $7,588,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Cantor Fitzgerald Investment Advisors L.P. grew its holdings in CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after acquiring an additional 6,615 shares during the period. Brandywine Global Investment Management LLC raised its holdings in CVS Health by 20.1% in the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after purchasing an additional 572,533 shares during the period. Holderness Investments Co. bought a new position in shares of CVS Health during the first quarter worth $300,000. Red Mountain Financial LLC acquired a new position in shares of CVS Health in the 2nd quarter valued at $293,000. Finally, AE Wealth Management LLC increased its position in shares of CVS Health by 607.5% in the 2nd quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock valued at $16,708,000 after buying an additional 207,984 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CVS. Barclays boosted their target price on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Wolfe Research increased their target price on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday. Piper Sandler lifted their price target on shares of CVS Health from $81.00 to $99.00 in a research note on Friday, October 31st. Argus upped their price target on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Finally, Leerink Partners boosted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 16th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $91.67.

CVS Health Price Performance

NYSE:CVS opened at $78.31 on Wednesday. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $85.15. The company has a market cap of $99.41 billion, a P/E ratio of 206.08, a P/E/G ratio of 0.75 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock’s 50-day simple moving average is $78.82 and its 200 day simple moving average is $71.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s revenue was up 7.8% compared to the same quarter last year. During the same period last year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date was Thursday, October 23rd. CVS Health’s payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.